Lunch and Learn highlights | Boston
When
April 10, 2025
11:30 a.m. - Registration & Lunch
12:00 p.m. - Speaker presentation starts
Fee: No Cost.
Limited Seats.
Register below.
Agenda
Journey through the world of RNA vaccines and therapeutics | Explore saRNA, CRISPR, and modified nucleotides
Kate Broderick, PhD
Chief Innovation Officer, Maravai LifeSciences
Dr. Kate Broderick is the Chief Innovation Officer at Maravai LifeSciences, leading scientific innovation in nucleic acid technologies. Previously, she spent 15 years at Inovio Pharmaceuticals, spearheading vaccine development for diseases like Ebola, Zika, and COVID-19. She holds a Ph.D. from the University of Glasgow and conducted postdoctoral research at UC San Diego.
Questions?
Email us at marketing@trilinkbiotech.com
TriLink BioTechnologies does not sell or distribute your information to third parties. For more information, please refer to our Privacy Policy